1. Performance Measures Related to Colposcopy for Canadian Cervical Cancer Screening Programs: Identifying Areas for Improvement 
Kathleen M. Decker, PhD, C. Meg McLachlin, MD, FRCPC, Robert Lotocki, MD, FRCPC 
Journal of Obstetrics and Gynaecology Canada  
Volume 37, Issue 3, Pages (March 2015)
DOI: /S (15)
Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions

2. Figure 1
Percentage of women 20 to 69years of age who had an ASC-H, HSIL, or more severe Pap test result, colposcopy, and a biopsy within 12months of the Pap test by province (2009 and 2010)
HSIL or more severe: high-grade squamous intraepithelial lesions, carcinoma in situ, and invasive carcinoma; NS: Nova Scotia; AB: Alberta; BC: British Columbia; MB: Manitoba.
Journal of Obstetrics and Gynaecology Canada   , DOI: ( /S (15) )
Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions

3. Figure 2
Percentage of women 20 to 69years of age who had an ASC-H or HSIL or more severe Pap test result with histological work-up and who had a pre-cancerous or cancerous lesion (CIN 2 and CIN 3+) in the 12months after the Pap test by province
HSIL+: high-grade squamous intraepithelial lesions, carcinoma in situ, and invasive carcinoma; BC: British Columbia; PE: Prince Edward Island; NS: Nova Scotia; AB: Alberta; MB: Manitoba.
Journal of Obstetrics and Gynaecology Canada   , DOI: ( /S (15) )
Copyright © 2015 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions